Archives
-
HRP Goat Anti-Rabbit IgG: From Signal to Evidence
2026-09-14
Discover how Affinity-Purified Goat Anti-Rabbit IgG (H+L) supports rigorous Western blot, ELISA, and immunohistochemistry workflows. This article connects HRP-based signal generation with the evidence architecture used to investigate PSMD13 and immune features in hepatocellular carcinoma.
-
PP 2 (AG 1879): A Mechanistic Assay Guide
2026-09-14
PP 2 (AG 1879) is a selective Src-family kinase probe for connecting phosphorylation events with cell behavior. This guide applies the compound to cancer research, T cell signaling, and a new decidualization assay framework grounded in the PA–Src–FAK–RhoA/ROCK pathway.
-
N2703 in Adipose-Neural Cardiac Assays
2026-09-13
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can support causal assay design around adipose-neural signaling and cardiac electrophysiology. This article emphasizes controls, interpretation, and translational limitations rather than repeating a general pathway overview.
-
FPR2/ALX, Microglia, and Autoimmune Astrocytopathy
2026-09-12
This study identifies FPR2/ALX stimulation with Quin-C1 as a way to limit AQP4-IgG- and complement-driven astrocytopathy in mice by coordinating microglial and natural killer cell responses. Its depletion and kinase-inhibition experiments connect the protective phenotype to microglia, NK cells, and SYK-AKT signaling, while also defining important limits for translation to human NMOSD.
-
Sildenafil Citrate and the Proteoform Precision Shift
2026-09-11
Sildenafil Citrate offers a mechanistically defined route into cGMP biology, while native-membrane proteomics reveals why target selectivity must be evaluated at the proteoform level.
-
Bacitracin B1670: Practical Research Guide
2026-09-11
Bacitracin B1670 is a peptide antibiotic for controlled antibacterial research focused on bacterial cell wall and peptidoglycan synthesis disruption. This guide covers solvent selection, stock preparation, assay controls, storage, and interpretation boundaries; it is not intended for diagnostic, clinical, therapeutic, or other medical use.
-
Ginsenoside Rg2 and Alzheimer’s BBB Integrity
2026-09-10
The reference study shows that ginsenoside Rg2 can reduce astrocyte-driven inflammation and improve blood-brain barrier tightness in complementary mouse, endothelial-cell, astrocyte, and co-culture models of Alzheimer’s disease-related injury. Its main contribution is a mechanistic model linking reduced astrocyte activation and TLR4/MyD88/MMP9 signaling with preservation of endothelial tight junctions, while also identifying oxidative stress as a relevant pathway.
-
Oridonin Targets Inflammation in Esophageal Cancer
2026-09-10
Peng et al. report that oridonin attenuated esophageal lesions and inflammatory signaling in a 4-NQO-induced mouse model, with effects associated with suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. The study links inflammatory pathway modulation with changes in proliferation, apoptosis, systemic blood indices, and tissue pathology, while also highlighting the need for mechanistic and translational validation.
-
Tariquidar: Decoding Mechanobiology-Driven Chemoresistance
2026-09-09
Tumor viscosity is emerging as a mechanobiological driver of P-glycoprotein upregulation and chemotherapy resistance. This article connects that finding to Tariquidar (XR9576), outlining how selective ABCB1 inhibition can distinguish transporter activity from upstream mechanical signaling and strengthen translational drug resistance research.
-
Gallein and the Next Frontier of GPCR Translation
2026-09-09
Gallein offers translational researchers a way to interrogate G protein βγ-dependent signaling across cancer, immune, cardiac, and emerging metabolic questions. By connecting validated disease models with the lactate-GPR81/FARP1 discovery, this article frames Gallein as a strategic mechanistic tool rather than a conventional single-indication compound.
-
VER 155008: Hsp70 Assay Design and Interpretation
2026-09-08
VER 155008 is an adenosine-derived HSP 70 inhibitor for connecting Hsp70 ATPase inhibition with apoptosis, proteostasis failure, and cancer cell proliferation inhibition. This guide develops an assay-centered framework that distinguishes biochemical target engagement from cellular response and proteomic interpretation.
-
Resveratrol and Radiation-Induced Endothelial Injury
2026-09-08
This study establishes an in vitro endothelial model for rapidly screening compounds that repair ionizing-radiation injury rather than merely preventing it. Resveratrol produced a concentration-dependent hormetic response, with 0.1 μM reported as the optimal concentration for restoring DNA integrity, tube formation, and endothelial protein organization.
-
L-Alanyl-L-Glutamine: Practical GI Workflow
2026-09-07
L-Alanyl-L-Glutamine (SKU B8228) provides a defined, water-soluble L-Ala-L-Gln dipeptide for gastrointestinal barrier, mucosal, and nutritional-support workflows. This guide focuses on preparation, controls, and QC; it should not be treated as evidence for a specific dose, disease model, clinical outcome, or non-GI application.
-
AP1903: A Causal Control Layer for Entry Assays
2026-09-07
AP1903 is an FKBP-binding ligand that enables controlled protein activation and precise perturbation of engineered cells. This article connects its dimerization logic with multiplexed pseudovirus assays, showing how to separate receptor compatibility, downstream signaling, and conditional cell ablation.
-
QPRT Drives Breast Cancer Invasion via PLC Signaling
2026-09-05
The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a promoter of breast cancer migration and invasion and connects this phenotype to myosin light chain phosphorylation. Its inhibitor-based experiments place purinergic, Rho/ROCK, phospholipase C, and MLCK signaling within a candidate pathway that can be tested with genetic and pharmacological controls.